AGMB
AgomAb Therapeutics NV
Nasdaq Biological Products, (No Diagnostic Substances) Non-accelerated filer
Emerging growth company

Key Financials

Recent SEC Filings

Form Type Filed Date Link
6-K 10/1/2026 View on SEC
4 9/15/2026 View on SEC
4 9/15/2026 View on SEC
3 9/15/2026 View on SEC
3 9/15/2026 View on SEC
6-K 9/14/2026 View on SEC
6-K 9/11/2026 View on SEC
6-K 8/10/2026 View on SEC
6-K 8/6/2026 View on SEC
6-K 6/23/2026 View on SEC

Company Information

Field Value
Ticker AGMB
Company Name AgomAb Therapeutics NV
CIK 2020932
Sector Biological Products, (No Diagnostic Substances)
Industry Non-accelerated filer
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type other
Fiscal Year End 1231
State of Incorporation C9
Phone 32 3 302 35 30